RECRUITING

Black Church Treatment Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will conduct a randomized clinical trial comparing levels of treatment initiation, engagement, and alcohol outcomes for a novel treatment strategy (CBT4CBT delivered in the Black church) compared with traditional outpatient specialty addiction treatment for a large sample of Black adults with AUD. The purpose of this randomized clinical trial is to determine which setting (church or specialty clinic) (1) has better treatment initiation and retention rates and (2) better AUD outcomes as measured by percentage of days abstinent (PDA) (8 weeks, 3, 6 and 9 months follow up).

Official Title

Addressing Health Disparities by Providing Evidence-Based Treatment in the Black Church

Quick Facts

Study Start:2021-07-07
Study Completion:2026-10-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04580810

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * at least 18 years of age
  2. * current AUD as their principal substance use disorder, confirmed via MINI100 interview, with some drinking in the past 28 days
  3. * English-speaking
  1. * inability to provide informed consent or participate in the study procedures as proposed in the consent
  2. * active suicidal or homicidal ideation or an unstable psychotic disorder (schizophrenia, schizoaffective disorder) or mood disorder (bipolar disorder, severe major depressive disorder),
  3. * current engagement in substance use treatment, and
  4. * an unwillingness to be randomized to either condition. Individuals with comorbid substance use disorders will be included, as multiple substances of use are common in this population.

Contacts and Locations

Study Contact

Traci Norman
CONTACT
203-833-4267
Traci.Norman@nyulangone.org

Principal Investigator

Ayana Jordan, MD, PhD.
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

Beulah Heights First Pentecostal Church
New Haven, Connecticut, 06511
United States
Dixwell Ave Congregational United Church of Christ
New Haven, Connecticut, 06511
United States
The Substance Abuse Training Unit (SATU)
New Haven, Connecticut, 06511
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Ayana Jordan, MD, PhD., PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-07-07
Study Completion Date2026-10-31

Study Record Updates

Study Start Date2021-07-07
Study Completion Date2026-10-31

Terms related to this study

Additional Relevant MeSH Terms

  • Alcohol Use Disorder